8th Jul 2019 12:09
(Alliance News) - Braveheart Investment Group PLC on Monday said it has acquired a 33% holding in Pharm2Farm Ltd for an undisclosed sum.
P2F is a spin out from Nottingham Trent University, which has developed and patented a process to increase the bioavailability of trace minerals in plant feeds.
The fund management company said the process uses nanotechnology to improve trace element take-up in both flower and crop farming.
Braveheart said this technology was initially developed to enrich the nutritional value of potatoes. Preliminary results not only showed a 20% increase in iron uptake by the tubers, but also an increase in yield and an approximate two-week reduction in the time to harvest.
This patented technology has now been developed for use in the growing of other commercial crops, both in soil and hydroponically, the AIM-listed company explained.
Looking ahead, Braveheart said it believes that there is a market opportunity for this technology and is in negotiations to take it's shareholding in P2F to 54% by way of a working capital investment.
Braveheart shares were trading 2.6% higher on Monday in London at 10.00 pence each.
Related Shares:
Braveheart Investments